Ronda Schreiber

Dr. Ronda Schreiber has a comprehensive work history in the field of biotechnology and regenerative medicine. Ronda has held various leadership positions in companies like Angiocrine Bioscience, Inc., Organogenesis Inc., Shire, Minnow Medical, Cytori Therapeutics, Advanced Tissue Sciences, and Telios Pharmaceuticals. Their roles have ranged from Director of Orthobiologics to Vice President of Research, with responsibilities including directing product development, translational research, quality assurance, and project management. Dr. Schreiber's expertise lies in technical operations and translational research within the biotechnology sector.

Ronda Schreiber, Ph.D. obtained their degree in Biochemistry from Mount Sinai / City University of New York. Ronda also holds a Biotechnology Project Management Certification from UC San Diego and U. Washington.